DM Review

DM Clinical Research is a leading multi-therapeutic clinical trial site network and site management organization (SMO) headquartered in Houston, Texas. Founded in 2006, the company operates an extensive network of research sites across the United States, partnering with global pharmaceutical companies and contract research organizations (CROs) to conduct Phase I through Phase IV clinical trials. The organization gained significant prominence for its role in large-scale vaccine development, including pivotal trials for COVID-19, flu, and RSV. DM Clinical Research provides comprehensive site services, including rapid patient recruitment, regulatory management, and high-quality data collection across diverse therapeutic areas such as internal medicine, neurology, and pediatrics.